New combo therapy offers hope for recurrent head and neck cancer patients
NCT ID NCT04373642
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests a new treatment for people whose head and neck cancer has come back. It combines a short course of radiation called QUAD SHOT with an immunotherapy drug called pembrolizumab. The goal is to see if this combination is safe and helps shrink tumors or improve quality of life. About 30 adults with recurrent head and neck cancer are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.